Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT(1A) Agonist, in Patients With Parkinson Disease Psychosis: A Pilot Study

BACKGROUND AND OBJECTIVES: Ulotaront (SEP-363856) is a trace amine-associated receptor 1 agonist with 5-HT(1A) receptor agonist activity currently in phase 3 clinical development for the treatment of schizophrenia. In this exploratory, flexibly dosed study, ulotaront was evaluated for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaacson, Stuart H., Goldstein, Mark, Pahwa, Rajesh, Singer, Carlos, Klos, Kevin, Pucci, Michael, Zhang, Yi, Crandall, David, Koblan, Kenneth S., Navia, Bradford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238151/
https://www.ncbi.nlm.nih.gov/pubmed/37273942
http://dx.doi.org/10.1212/CPJ.0000000000200175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238151/
https://www.ncbi.nlm.nih.gov/pubmed/37273942
http://dx.doi.org/10.1212/CPJ.0000000000200175

Ejemplares similares